Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients.

American journal of hematology - 1 Jun 2016

Haider Mahnur, Gangat Naseema, Lasho Terra, Abou Hussein Ahmed K, Elala Yoseph C, Hanson Curtis, Tefferi Ayalew

Abstract excerpt

The primary objective of treatment in essential thrombocythemia (ET) is to prevent thromboembolic complications. In this regard, advanced age and thrombosis history have long distinguished "low" from "high" risk patients. More recently, JAK2V617F and cardiovascular (CV) risk factors were identified as additional modifiers, leading to the development of a 3-tiered International Prognostic Score of Thrombosis for...

Topics

Join the communities discussing this publication.

Aged, 80 and over
Janus Kinase 2
Prognosis
Reproducibility of Results
Risk Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Thrombocythemia, Essential

Source

Identifiers

PMID: 26799697
DOI: 10.1002/ajh.24293

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients.PMID 26799697Read ↗

New and treatment-relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera.Semantic proximity Read ↗

Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis.Semantic proximity Read ↗

Development and validation of a multiple factor-based prognostic score system of thrombosis in polycythemia vera (MFPS-PV)Semantic proximity Read ↗

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.Semantic proximity Read ↗

Risk factors for thrombosis and bleeding and their influence on therapeutic decisions in patients with essential thrombocythemia.Semantic proximity Read ↗

Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.Semantic proximity Read ↗

Predictive factors of thrombosis for patients with essential thrombocythaemia: A single center study.Semantic proximity Read ↗

The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis.Semantic proximity Read ↗

It is time to change thrombosis risk assessment for PV and ET?Semantic proximity Read ↗

Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.Semantic proximity Read ↗

Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.Semantic proximity Read ↗

[Clinical characteristics and risk factors for major thrombosis in 604 Chinese patients with low-risk essential thrombocythemia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.